Belladonna — the beauty that kills (anatomy of a forbidden plant)

Les plantes qu'on a brûlées avec les femmes. On ne les vend pas. On les nomme.

tagline · path

Les plantes qu'on a brûlées avec les femmes. On ne les vend pas. On les nomme.

— Les plantes qu'on a brûlées avec les femmes. On ne les vend pas. On les nomme.

Why we refuse — TL;DR

INFUSE will not sell Atropa belladonna. Three reasons hold this refusal in place.

1. Toxicity of surgical precision: belladonna's atropine and scopolamine act at minuscule doses. Three berries are enough to kill a child. No recreational, cosmetic, or wellbeing use can stand against that precision.
2. A long European memory: belladonna is the plant of medieval witches, of sabbath ointments, of the Inquisition's pyres. She carried hundreds of knowing women to the stake — herbalists, midwives, keepers of the threshold. To sell her as a product is to miss everything that memory has to pass on.
3. Cosmetic misuse: the Renaissance fashion among Italian ladies who dilated their pupils with drops of belladonna ("beautiful woman," from bella donna) left a toxic trace — cosmetic products that to this day still contain tropane derivatives. INFUSE refuses that logic of using the body as an instrument.

The history — who truly knew this plant

Belladonna has a European history of rare density. She appears in the Roman pharmacopoeia under the pen of Dioscorides in the first century AD — he calls her strychnon manikon, "the nightshade that drives one mad." Pliny the Elder ranks her among the plants "of Medea," the poisoner-queen of Greek mythology. The name Atropa itself points back to Atropos, the one of the three Fates who cuts the thread of life. The name is a warning.

In the Middle Ages, belladonna entered the monastic pharmacopoeia. Hildegard of Bingen, the twelfth-century Rhenish abbess, mentions the plant in her Physica with a clear recommendation: entrust her only to those who know, and always in a mixture tempered by other simples. At the same time, in the villages, midwives used her in minute doses for the pains of childbirth, for the spasms of asthmatic bronchi, for diagnostic pupil dilation.

The Italian Renaissance gave her her modern name: bella donna, beautiful lady. Noble Venetian and Florentine women instilled a few drops of berry juice into their eyes to dilate the pupils — a gesture read as seductive, because a dilated pupil signals (to another's eye) a state of amorous arousal. The plant thus took on a cosmetic use that would last into the nineteenth century, despite repeated cases of permanent visual damage.

At the same time, in northern Europe — Germany, the Baltic lands, Scandinavia — belladonna entered the so-called "witches'" ointments. Blended with henbane, datura, and mandrake in a base of animal fat, the ointment was applied to the sensitive mucous membranes to bring on visionary states. The Inquisition records of the sixteenth and seventeenth centuries describe these practices with an unwitting precision — which makes them, paradoxically, among the best sources we have on pre-modern folk pharmacopoeia.

Those sources say something else too: the women burned as witches knew exactly what they were doing. They commanded doses, preparations, and combinations that masculine academic medicine did not. The suppression of witchcraft is also the suppression of a European herbal knowledge — a knowledge we have never recovered.

In the nineteenth century, the isolation of atropine (1819, by the German chemists Mein, Geiger, and Hesse) let official medicine recover a fraction of the herbalists' knowledge — in pure molecular form, prescribable, controllable. The whole plant gradually left the pharmacopoeia. Today, pure atropine remains an essential hospital medicine: an antidote to organophosphate poisoning, an emergency treatment for certain bradycardias, used in diagnostic ophthalmology. The plant herself no longer holds any recognized therapeutic indication in modern medicine.

What remains of this history

• A European memory of the sabbath, the ointments, the pyres — one that does not fade
• A lost feminine herbal knowledge, of which we recover only fragments
• A modern pharmacopoeia (pure atropine, pure scopolamine) that owes everything to the plant but no longer names her
• An Italian cosmetic imaginary (bella donna, pupil dilation) that left a toxic trace
• A name — Atropa — reminding us that this plant cuts the thread

The pharmacology — surgical precision, no margin

Belladonna shares with her Solanaceae cousins (datura, henbane, mandrake) the pharmacological profile of the anticholinergics. Three principal alkaloids: atropine (the racemic form, mostly present after drying or chemical treatment), l-hyoscyamine (the form naturally found in the fresh plant), scopolamine (in lower concentration than in datura).

Mechanism: competitive antagonism of acetylcholine's muscarinic receptors. Clinical consequences: mydriasis (pupil dilation — the effect sought by the Italian women of the Renaissance), tachycardia, dryness of the mucous membranes, hyperthermia, urinary retention, slowed digestion, and beyond a certain dose, central confusion, hallucinations, convulsions, coma.

Pharmacological precision is what sets belladonna apart from datura. Where datura's alkaloid concentration varies by a factor of one to ten, belladonna's is more stable: between 0.3 and 0.6% in the leaves, up to 0.8% in the berries. That stability allowed her traditional medical use — but it changes nothing about the fact that the margin between an effective dose and a fatal one is extremely narrow. Three berries are enough to kill a child; five to twenty, depending on body weight, for an adult.

Contemporary European pharmacopoeia no longer uses the whole plant or her tincture. Isolated atropine remains an essential emergency medicine — but in pure molecular form, measured to the milligram, administered by injection in a hospital setting.

Why today's market is troubling

Belladonna is present on the market today in three principal forms, all of them, to our mind, troubling.

First form: homeopathic granules. Belladonna 5CH, 9CH, 30CH are available over the counter. At those extreme dilutions, mathematically not a single molecule of the plant remains (past 12CH, you are below Avogadro's number). It is a debate INFUSE has no need to settle — homeopathy has its defenders and its critics, and our objection does not lie there. Our objection is that homeopathic use sustains the trivializing idea that belladonna is a familiar, everyday plant with no real danger. That is misleading about the very nature of the plant.

Second form: mother tinctures and galenic preparations available through certain herbalist channels. Here the effective dose is real, and so is the toxicological risk. No serious therapeutic indication justifies these preparations in 2026. Everything belladonna once did, safer plants do, or modern medicine does with pure atropine.

Third form: residual cosmetic uses. Certain products called "natural" or "ancestral" still contain tropane derivatives of belladonna, henbane, or thorn-apple. The logic is the old one of the Italian Renaissance women — to open the gaze, dilate the pupil, manufacture an appearance of vivacity. It is a logic of using the body as an instrument that INFUSE refuses outright, whatever the plant vehicle.

To this is added — as with Datura — the cases of accidental poisoning. Children mistake belladonna's berries (black, glossy, sweet on the tongue) for bilberries or blackcurrants. Each summer, France's poison control centers field calls about poisonings from foraged wild berries. A handful of documented child deaths per decade.

INFUSE's ethical reasons for not selling

First reason — the precision required

Belladonna, unlike datura, can be dosed with precision. That is, paradoxically, what makes her a more treacherous trap. Datura will never be seriously commercialized because it is impossible to calibrate. Belladonna can be calibrated — but the margin stays so narrow that no consumer brand can hold the responsibility for a dosing error. We refuse to hold that responsibility.

Second reason — the memory of the pyres

The women who knew belladonna — in the most precise sense of the word — were burned. That memory weighs. To sell belladonna today as an "ancestral" or "sacred feminine" product without naming that memory is to betray twice over. It betrays the burned women (taking their knowledge without naming them), and it betrays the buyers (selling them an imaginary of feminine power while selling them a deadly plant). INFUSE refuses that double lie.

Third reason — the cosmetic

The cosmetic use of belladonna, going back five centuries, rests on a logic of using the body as an instrument: altering appearance to signal a state (amorous arousal, vivacity) one does not actually feel. That is exactly the advertising posture INFUSE refuses. Our products signal nothing to anyone — they accompany a body that feels itself.

Fourth reason — the child who eats the berries

As long as a highly toxic plant stays in the commercial landscape, she keeps a diffuse trivialization alive — people planting her in their gardens for her dark, beautiful ornamental look, children crossing paths with the berries unwarned, avoidable accidents. INFUSE will never take part in that landscape of trivialization.

For those who still want to approach: the legitimate paths

Three paths, in order of useful likelihood.

1. Study the history. Read Hildegard of Bingen, read Susun Weed, read the Inquisition records (the Malleus Maleficarum, but also more recent sources such as Jeffrey Burton Russell). Understand that belladonna is inseparable from a history of European violence against knowing women. That understanding is more precious than consumption.
2. Meet the living plant. Belladonna grows in France, in limestone undergrowth. A botanical encounter — observing her, drawing her, learning her seasons, her pollination — carries no risk and a great deal of meaning. The berries let themselves be admired without being touched.
3. Do not look for the use. If the plant calls to you, it is probably not to consume her. It is to mend, in your own measure, a cut thread of memory. That can take the form of research, of a piece of writing, of care given to another woman. That is enough.

Nuggets & legends

A few fragments worth keeping.

• The name Atropa points back to Atropos, one of the three Fates of Greek mythology. Clotho spins the thread of life, Lachesis measures it, Atropos cuts it. Linné, naming the plant in 1753, chose that Fate — the one of the cut. The name is a scientific warning.
• In imperial Rome, the emperor Augustus is said to have died poisoned by his wife Livia, by means of figs smeared with belladonna juice (according to the rumor reported by Tacitus and Suetonius). Belladonna would thus have changed the course of the Empire. History or legend — the botanical possibility is real.
• In eleventh-century Scotland, according to a tradition reported by Hector Boece, the army of King Duncan is said to have poisoned the Danish troops of Sweno by mixing belladonna into wine offered during a truce. The Danes, dulled by anticholinergic delirium, were massacred at dawn. This is the origin of the legendary "sleep-wine."
• Dried belladonna leaves, smoked, were used in the nineteenth century in certain preparations against asthma — under the trade names "anti-asthmatic powders" or "Datura cigarettes" (which blended the two solanaceous plants). This use, abandoned in the early twentieth century, did real harm.
• Carl von Linné, in Species Plantarum (1753), places belladonna in the genus Atropa, which he invents for her — a genus that, in modern classification, contains only four species, all highly toxic. It is one of the rare botanical genera composed entirely of deadly plants.
• Belladonna's flowers are visited by certain hymenoptera (bumblebees, wasps), which are unaffected by the anticholinergic alkaloids — their nervous system is different. The plant makes a poison against mammals, not against her pollinators. The specificity is itself a signature.
• In the nineteenth century, the use of atropine in ophthalmology for diagnostic pupil dilation opened the way for fundoscopy — examination of the back of the eye. Without belladonna, modern ophthalmology would have advanced more slowly. That is a debt worth naming.